CoChat

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping

Open access
Kim, Hye-Ryoun, Lee, Sung Yong, Hyun, Dae-Sung, Lee, Min Ki, Lee, Hyun-Kyung, Choi, Chang-Min, Yang, Sei-Hoon, Kim, Young-Chul, Lee, Yong Chul, Kim, Sun Young, Jang, Seung Hun, Lee, Jae Cheol, Lee, Kye Young · 2013 · Journal of Experimental & Clinical Cancer Research
Cited by 107

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background: Epidermal growth factor receptor (EGFR)-activating mutations are major determinants in predicting the tumor response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC). Noninvasive test for the detection of EGFR mutations is required, especially in NSCLC patients from whom tissue is not available. In this study, we assessed the feasibility of detection of EGFR mutations in free DNA circulating in plasma. Methods: Plasma samples of 60 patients with partial response to gefitinib were analyzed to detect EGFR-activating mutations in exons 19 and 21. Forty (66.7%) of patients had tumor EGFR mutation results. EGFR mutations in plasma were detected using the peptide nucleic acid (PNA)-mediated polymerase chain reaction (PCR) clamping method. All clinical data and plasma samples were obtained from 11 centers of the Korean Molecular Lung Cancer Group (KMLCG). Results: Of the 60 patients, 39 were female and the median age was 62.5 years. Forty-three patients never smoked, 53 had adenocarcinomas, and seven had other histologic types. EGFR-activating mutation was detected in plasma of 10 cases (exon 19 deletion in seven and exon 21 L858R point mutation in three). It could not be found in plasma after treatment for 2 months. When only patients with confirmed EGFR mutation in tumor were analyzed, 17% (6 of 35) of them showed positive plasma EGFR mutation and the mutation type was completely matched with that in tumor. There was no statistically significant difference in clinical parameters between patients with EGFR mutations in plasma and those without EGFR mutations. Conclusions: The detection rate of EGFR mutations from plasma was not so high despite highly sensitive EGFR mutation test suggesting that more advances in detection methods and further exploration of characteristics of circulating free DNA are required.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1756-9966-32-50

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 107

Metadata

Authors
Kim, H.-R., Lee, S. Y., Hyun, D.-S., Lee, M. K., Lee, H.-K., Choi, C.-M., Yang, S.-H., Kim, Y.-C., Lee, Y. C., Kim, S. Y., Jang, S. H., Lee, J. C., & Lee, K. Y.
Venue
Journal of Experimental & Clinical Cancer Research
Published
2013-08-09
Volume
32
Issue
1
Pages
50-50
ISSN
  • 0392-9078 (ISSN-L)
  • 1756-9966
OpenAlex
W2170481827
Cited by
107
References
4
FWCI
9.74
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping. https://app.cochat.ai/papers/10.1186/1756-9966-32-50
The paper
Kim, H.-R., Lee, S. Y., Hyun, D.-S., Lee, M. K., Lee, H.-K., Choi, C.-M., Yang, S.-H., Kim, Y.-C., Lee, Y. C., Kim, S. Y., Jang, S. H., Lee, J. C., & Lee, K. Y. (2013). Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/1756-9966-32-50

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.